Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Viral myocarditis (mmu05416)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
14927508
3
KLA  ATP  ATP+KLA
 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69
ATP .85 .69 1.26 .89 .89 1.26 .64
KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82
Abl1
KLA  ATP  ATP+KLA
 AK083248 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630031E05 product:v-abl Abelson murine leukemia oncogene 1, full insert sequence. [AK083248] KLA 1.07 1.07 .92 1.01 .98 1.07 .98
ATP .98 .99 .94 .90 .99 1.07 1.04
KLA/ATP 1.04 1.01 1.03 .98 .97 .95 .99
Abl1
KLA  ATP  ATP+KLA
 NM_009594 c-abl oncogene 1, receptor tyrosine kinase (Abl1), transcript variant 2, mRNA [NM_009594] KLA .63 .62 .65 .71 .96 1.17 1.05
ATP 1.01 1.16 1.03 1.14 1.12 .98 .98
KLA/ATP .66 .64 .67 .73 .84 .90 1.05
Abl2
KLA  ATP  ATP+KLA
 NM_009595 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) (Abl2), mRNA [NM_009595] KLA 1.26 1.26 1.10 1.05 .90 1.02 1.10
ATP 1.01 1.21 2.17 2.69 2.85 1.53 1.35
KLA/ATP 1.23 1.31 1.44 1.47 2.45 1.54 1.39
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Bid
KLA  ATP  ATP+KLA
 NM_007544 BH3 interacting domain death agonist (Bid), mRNA [NM_007544] KLA 1.03 1.08 1.09 1.14 1.01 .99 .68
ATP 1.06 1.11 .97 .89 1.04 1.17 1.08
KLA/ATP .88 1.09 .92 1.06 1.16 1.28 1.56
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp8
KLA  ATP  ATP+KLA
 NM_009812 caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812] KLA 2.41 2.53 3.20 3.26 2.75 2.78 1.57
ATP .91 .96 .66 .67 .54 1.53 1.52
KLA/ATP 2.47 2.52 2.08 2.41 1.41 2.50 2.77
Casp9
KLA  ATP  ATP+KLA
 NM_015733 caspase 9 (Casp9), mRNA [NM_015733] KLA .31 .31 .40 .66 .89 1.19 .91
ATP .88 .77 .91 .59 .43 .75 .93
KLA/ATP .26 .26 .30 .28 .80 1.06 .97
Cav1
KLA  ATP  ATP+KLA
 NM_007616 caveolin, caveolae protein 1 (Cav1), mRNA [NM_007616] KLA 14.41 13.85 11.14 10.72 9.47 4.26 1.52
ATP 1.05 1.13 1.37 1.72 3.27 15.82 13.01
KLA/ATP 12.62 15.59 16.15 16.68 11.37 8.19 14.27
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Cd28
KLA  ATP  ATP+KLA
 NM_007642 CD28 antigen (Cd28), mRNA [NM_007642] KLA .52 .51 .45 .50 .36 .33 .18
ATP 1.11 1.26 1.08 1.25 1.99 1.42 2.08
KLA/ATP .51 .51 .58 .60 .56 .53 .38
Cd40
KLA  ATP  ATP+KLA
 NM_170701 CD40 antigen (Cd40), transcript variant 3, mRNA [NM_170701] KLA 23.87 23.62 23.26 23.98 22.07 17.37 5.34
ATP 1.00 1.01 1.06 2.96 2.65 3.03 1.70
KLA/ATP 22.77 23.79 29.67 28.85 28.08 21.62 13.02
Cd40lg
KLA  ATP  ATP+KLA
 NM_011616 CD40 ligand (Cd40lg), mRNA [NM_011616] KLA 1.03 1.07 1.02 .98 1.06 1.06 1.03
ATP .95 .92 .99 1.06 1.02 1.04 1.07
KLA/ATP 1.00 1.01 .93 1.04 .94 1.01 .98
Cd55
KLA  ATP  ATP+KLA
 AF143541 decay accelerating factor glycosylphoshatidylinositol-anchored form (DAF) mRNA, partial cds. [AF143541] KLA .98 1.01 1.05 1.08 .98 .99 1.03
ATP 1.01 1.00 .95 .96 1.04 1.06 1.00
KLA/ATP 1.01 .99 1.05 .97 1.03 .97 .96
Cd55
KLA  ATP  ATP+KLA
 AK030285 11 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:5031405O06 product:decay accelerating factor 1, full insert sequence [AK030285] KLA 1.28 1.22 1.35 1.29 1.26 1.42 2.37
ATP 1.02 .96 1.02 1.00 .92 .98 1.32
KLA/ATP 1.30 1.22 1.19 1.04 .96 1.02 1.33
Cd55
KLA  ATP  ATP+KLA
 NM_010016 CD55 antigen (Cd55), mRNA [NM_010016] KLA 1.81 1.70 1.81 1.92 2.16 2.13 4.63
ATP 1.09 1.04 1.16 1.05 1.14 1.32 1.92
KLA/ATP 1.80 1.89 1.79 1.56 1.26 1.39 3.24
Cd80
KLA  ATP  ATP+KLA
 NM_009855 CD80 antigen (Cd80), mRNA [NM_009855] KLA 2.13 1.91 1.89 1.78 1.29 1.00 .82
ATP .99 1.20 1.98 1.49 1.37 2.40 1.71
KLA/ATP 2.05 2.32 3.09 2.27 1.95 2.89 3.07
Cd86
KLA  ATP  ATP+KLA
 NM_019388 CD86 antigen (Cd86), mRNA [NM_019388] KLA 13.80 14.41 18.21 18.33 17.37 17.26 4.82
ATP 1.02 1.00 2.20 3.64 5.16 6.79 3.81
KLA/ATP 14.80 14.66 18.10 18.96 19.38 20.42 14.21
Cxadr
KLA  ATP  ATP+KLA
 NM_001025192 coxsackievirus and adenovirus receptor (Cxadr), transcript variant 1, mRNA [NM_001025192] KLA .94 1.00 1.07 .96 1.02 1.08 1.01
ATP .92 .96 1.00 1.05 .98 .98 .93
KLA/ATP .92 1.00 1.00 1.03 .99 1.01 1.04
Cxadr
KLA  ATP  ATP+KLA
 NM_009988 coxsackievirus and adenovirus receptor (Cxadr), transcript variant 2, mRNA [NM_009988] KLA 1.05 1.01 1.00 1.01 .97 .99 .94
ATP 1.03 1.00 1.00 .99 .99 1.04 1.02
KLA/ATP 1.01 1.02 1.02 .99 1.02 1.01 1.07
Cycs
KLA  ATP  ATP+KLA
 NM_007808 cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808] KLA 2.20 2.21 2.35 2.69 2.62 3.22 2.14
ATP .87 .89 1.31 1.05 1.06 1.20 1.26
KLA/ATP 1.88 2.04 2.86 2.26 2.57 2.45 2.03
Cyct
KLA  ATP  ATP+KLA
 NM_009989 cytochrome c, testis (Cyct), mRNA [NM_009989] KLA .93 1.01 1.00 .99 1.02 1.03 .96
ATP 1.01 .91 1.01 .99 .98 .95 .95
KLA/ATP 1.10 .96 .89 .89 1.10 1.05 .97
Daf2
KLA  ATP  ATP+KLA
 AK019553 adult male testis cDNA, RIKEN full-length enriched library, clone:4921540H11 product:decay accelerating factor 2, full insert sequence. [AK019553] KLA 1.04 .91 .97 .98 1.02 1.02 .95
ATP .97 1.03 .91 .96 .95 1.05 1.05
KLA/ATP .94 .99 1.00 1.00 .99 .97 1.02
Daf2
KLA  ATP  ATP+KLA
 NM_007827 decay accelerating factor 2 (Daf2), mRNA [NM_007827] KLA 1.06 .99 1.00 1.00 1.03 1.04 1.18
ATP 1.03 1.03 .93 1.05 .97 .85 .98
KLA/ATP 1.11 1.13 1.10 1.00 .93 1.05 1.02
Dag1
KLA  ATP  ATP+KLA
 NM_010017 dystroglycan 1 (Dag1), mRNA [NM_010017] KLA .74 .75 .67 .59 .62 .61 .66
ATP 1.16 1.24 .87 1.18 1.00 .91 1.17
KLA/ATP .88 .84 .53 .70 .75 .96 .90
Dmd
KLA  ATP  ATP+KLA
 AK044536 adult retina cDNA, RIKEN full-length enriched library, clone:A930019F21 product:DYSTROPHIN homolog [Mus musculus], full insert sequence. [AK044536] KLA 1.02 .99 .98 1.00 .94 1.06 1.02
ATP .94 1.06 .95 .96 1.00 1.00 1.02
KLA/ATP .98 1.07 1.01 .86 .96 1.02 1.04
Dmd
KLA  ATP  ATP+KLA
 NM_007868 dystrophin, muscular dystrophy (Dmd), mRNA [NM_007868] KLA 1.00 .99 1.00 1.02 1.02 1.00 1.03
ATP .99 1.03 1.02 1.03 1.00 1.01 1.00
KLA/ATP 1.03 1.03 1.01 1.01 1.03 1.04 .99
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Eif4g1
KLA  ATP  ATP+KLA
 NM_145941 eukaryotic translation initiation factor 4, gamma 1 (Eif4g1), transcript variant 1, mRNA [NM_145941] KLA 1.14 1.11 1.21 1.05 1.01 .97 1.13
ATP 1.05 1.13 1.02 .94 .91 .96 1.08
KLA/ATP 1.17 1.21 1.03 .95 .77 .80 .88
Eif4g2
KLA  ATP  ATP+KLA
 NM_001040131 eukaryotic translation initiation factor 4, gamma 2 (Eif4g2), transcript variant 2, mRNA [NM_001040131] KLA 2.40 2.29 2.62 2.64 2.99 2.58 1.98
ATP 1.11 1.29 1.03 1.17 1.22 1.42 .90
KLA/ATP 2.25 2.47 1.96 2.07 1.24 1.34 1.14
Eif4g2
KLA  ATP  ATP+KLA
 NM_013507 eukaryotic translation initiation factor 4, gamma 2 (Eif4g2), transcript variant 1, mRNA [NM_013507] KLA 1.75 1.82 2.01 1.93 2.28 1.80 1.75
ATP 1.15 1.25 .94 1.03 1.03 1.03 .73
KLA/ATP 1.86 1.97 1.17 1.35 .91 .95 .95
Eif4g3
KLA  ATP  ATP+KLA
 NM_172703 eukaryotic translation initiation factor 4 gamma, 3 (Eif4g3), mRNA [NM_172703] KLA 1.22 1.10 1.42 1.45 1.56 1.21 1.06
ATP 1.14 1.11 1.06 .99 .82 .81 .91
KLA/ATP 1.25 1.21 1.57 1.30 .87 .72 1.15
Fyn
KLA  ATP  ATP+KLA
 U70324 Fyn(T) (L-fyn(T)) mRNA, complete cds. [U70324] KLA 1.23 1.27 1.31 1.27 1.31 .87 .48
ATP .88 .71 .66 .75 .90 1.28 .51
KLA/ATP 1.12 1.01 .94 .84 1.25 1.51 .53
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-Bl
KLA  ATP  ATP+KLA
 NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80
ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47
KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39
H2-D1
KLA  ATP  ATP+KLA
 AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94
ATP .96 1.01 1.02 .95 1.05 1.00 .98
KLA/ATP .92 .94 .97 .97 .98 .92 1.03
H2-D1
KLA  ATP  ATP+KLA
 NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56
ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90
KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-K1
KLA  ATP  ATP+KLA
 M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99
ATP .98 .97 1.19 1.45 1.36 1.68 2.17
KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82
H2-K1
KLA  ATP  ATP+KLA
 NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17
ATP .98 .97 1.13 1.32 1.29 1.57 2.09
KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91
H2-M1
KLA  ATP  ATP+KLA
 NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04
ATP 1.01 .99 1.03 1.07 .92 1.03 .98
KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02
H2-M10.1
KLA  ATP  ATP+KLA
 NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94
ATP 1.06 1.04 .96 .95 .97 .98 .98
KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99
H2-M10.2
KLA  ATP  ATP+KLA
 NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40
ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66
KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92
H2-M10.3
KLA  ATP  ATP+KLA
 AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04
ATP .98 .96 1.00 .99 1.00 .99 1.00
KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03
H2-M10.4
KLA  ATP  ATP+KLA
 NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03
ATP 1.07 1.05 .97 1.08 .95 .97 1.02
KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04
H2-M10.5
KLA  ATP  ATP+KLA
 NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07
ATP 1.02 1.02 1.04 .90 1.03 .99 .99
KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04
H2-M10.6
KLA  ATP  ATP+KLA
 NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92
ATP 1.04 1.09 .96 .98 .94 1.07 .98
KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05
H2-M11
KLA  ATP  ATP+KLA
 NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03
ATP 1.02 .96 1.08 .98 1.04 .94 .98
KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99
H2-M3
KLA  ATP  ATP+KLA
 NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73
ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09
KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06
H2-M9
KLA  ATP  ATP+KLA
 NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03
ATP .96 1.06 .94 .96 1.05 1.06 1.00
KLA/ATP .96 1.01 1.01 .99 .97 .95 .98
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
H2-Q1
KLA  ATP  ATP+KLA
 NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00
ATP .99 .92 .93 1.01 1.01 1.04 1.00
KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04
H2-Q10
KLA  ATP  ATP+KLA
 NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18
ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69
KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93
H2-Q2
KLA  ATP  ATP+KLA
 NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47
ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88
KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43
H2-Q7
KLA  ATP  ATP+KLA
 NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76
ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00
KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48
H2-Q8
KLA  ATP  ATP+KLA
 NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27
ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26
KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43
H2-T22
KLA  ATP  ATP+KLA
 NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50
ATP 1.01 .95 .88 .92 .93 3.65 5.53
KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89
H2-T23
KLA  ATP  ATP+KLA
 NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43
ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49
KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06
H2-T24
KLA  ATP  ATP+KLA
 NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89
ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71
KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10
H2-T3
KLA  ATP  ATP+KLA
 NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00
ATP .98 1.08 1.03 1.01 .98 1.02 1.03
KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97
Icam1
KLA  ATP  ATP+KLA
 BC008626 intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] KLA 36.67 32.93 28.63 27.91 14.65 8.16 4.15
ATP .96 .88 1.50 3.88 4.98 3.90 1.01
KLA/ATP 32.58 31.60 42.74 32.60 26.00 13.02 6.01
Icam1
KLA  ATP  ATP+KLA
 NM_010493 intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] KLA 15.66 15.20 12.96 12.31 9.39 6.17 3.81
ATP .96 1.06 1.21 4.19 4.33 3.16 1.06
KLA/ATP 14.31 15.46 17.84 17.60 13.77 8.36 5.42
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Itgal
KLA  ATP  ATP+KLA
 AK156251 activated spleen cDNA, RIKEN full-length enriched library, clone:F830013L17 product:integrin alpha L, full insert sequence [AK156251] KLA 5.36 5.78 4.86 5.55 7.02 8.63 11.12
ATP .99 1.17 1.22 1.57 1.35 1.95 3.79
KLA/ATP 5.42 5.89 4.95 5.91 3.96 4.93 10.15
Itgal
KLA  ATP  ATP+KLA
 NM_008400 integrin alpha L (Itgal), mRNA [NM_008400] KLA 4.48 5.17 5.28 5.82 7.82 8.09 16.96
ATP 1.03 1.06 1.24 1.44 1.34 2.02 4.59
KLA/ATP 4.71 5.63 5.49 5.60 3.66 4.65 17.76
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Lama2
KLA  ATP  ATP+KLA
 AK046114 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230342M05 product:laminin, alpha 2, full insert sequence. [AK046114] KLA 1.06 1.00 .95 1.10 1.04 .99 .96
ATP .98 1.09 1.00 .97 .96 1.12 1.01
KLA/ATP .94 1.04 1.05 1.00 .99 1.00 .98
Lama2
KLA  ATP  ATP+KLA
 NM_008481 laminin, alpha 2 (Lama2), mRNA [NM_008481] KLA .96 .99 .96 1.02 .95 1.00 .97
ATP 1.05 1.00 1.01 .94 1.01 1.04 .96
KLA/ATP .99 1.04 1.06 1.10 .98 .95 .97
Lama2
KLA  ATP  ATP+KLA
 U12147 laminin-2 alpha2 chain mRNA, complete cds. [U12147] KLA .96 1.00 .99 1.00 .98 1.02 1.03
ATP 1.01 .99 1.02 1.04 1.01 .99 1.02
KLA/ATP 1.00 1.01 1.00 1.01 .99 1.04 1.00
LOC67670
8
KLA  ATP  ATP+KLA
 XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62
ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30
KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00
Mm.19506
1
KLA  ATP  ATP+KLA
 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83
ATP .97 .90 .96 .77 .80 3.98 5.87
KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38
Mm.25070
5
KLA  ATP  ATP+KLA
 7305294 Unknown KLA 1.01 1.06 1.00 1.05 .99 1.07 .99
ATP 1.00 1.05 1.06 1.03 .89 1.01 1.10
KLA/ATP 1.04 .92 1.05 1.07 1.00 1.00 1.05
Mm.25500
3
KLA  ATP  ATP+KLA
 161484596 Unknown KLA .35 .34 .35 .34 .22 .19 .10
ATP 1.09 1.27 1.13 1.29 2.25 1.66 2.22
KLA/ATP .38 .36 .39 .40 .49 .42 .32
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.43967
5
KLA  ATP  ATP+KLA
 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19
ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84
KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36
Mm.43967
5
KLA  ATP  ATP+KLA
 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43
ATP .96 .91 1.12 .90 .70 1.10 1.47
KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99
Mm.44165
1
KLA  ATP  ATP+KLA
 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10
ATP .91 .84 .96 .75 .78 3.91 6.03
KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63
Mm.45798
3
KLA  ATP  ATP+KLA
 118131045 Unknown KLA .95 1.08 1.17 1.13 1.10 1.13 1.06
ATP 1.02 .97 1.03 1.07 1.17 1.22 1.05
KLA/ATP 1.04 1.05 1.06 1.11 1.41 1.49 1.08
Myh1
KLA  ATP  ATP+KLA
 AK009974 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310058C22 product:myosin, heavy polypeptide 1, skeletal muscle, adult, full insert sequence [AK009974] KLA .98 .99 .95 1.03 .98 .98 .98
ATP .98 1.00 1.02 1.00 .99 1.01 .99
KLA/ATP .98 .95 1.05 1.06 1.01 1.00 1.06
Myh1
KLA  ATP  ATP+KLA
 NM_030679 myosin, heavy polypeptide 1, skeletal muscle, adult (Myh1), mRNA [NM_030679] KLA 1.04 .99 .98 1.04 1.04 1.00 1.05
ATP .95 1.02 1.09 1.02 .98 1.03 1.06
KLA/ATP 1.02 .98 1.05 1.01 .96 1.00 .99
Myh10
KLA  ATP  ATP+KLA
 NM_175260 myosin, heavy polypeptide 10, non-muscle (Myh10), mRNA [NM_175260] KLA 1.04 1.08 1.24 1.13 1.13 1.02 .77
ATP 1.06 1.09 1.04 1.04 .94 .84 .79
KLA/ATP 1.09 1.16 1.08 1.05 1.05 .88 .75
Myh11
KLA  ATP  ATP+KLA
 NM_013607 myosin, heavy polypeptide 11, smooth muscle (Myh11), mRNA [NM_013607] KLA 1.01 1.05 1.02 1.06 1.00 .96 1.01
ATP 1.09 .98 1.00 1.00 1.03 .97 1.13
KLA/ATP .99 1.06 1.05 1.03 .98 1.05 1.10
Myh13
KLA  ATP  ATP+KLA
 NM_001081250 myosin, heavy polypeptide 13, skeletal muscle (Myh13), mRNA [NM_001081250] KLA 1.01 1.04 1.01 .99 1.00 1.06 .97
ATP .99 1.02 1.05 1.08 .99 .98 1.01
KLA/ATP 1.01 .98 .99 1.02 1.06 1.00 1.01
Myh14
KLA  ATP  ATP+KLA
 NM_028021 myosin, heavy polypeptide 14 (Myh14), mRNA [NM_028021] KLA 1.10 1.12 1.05 1.07 1.10 1.06 1.07
ATP 1.02 1.04 1.03 1.02 1.01 1.04 1.10
KLA/ATP 1.02 1.07 1.06 1.04 1.13 1.10 1.13
Myh2
KLA  ATP  ATP+KLA
 AK036437 adult male bone cDNA, RIKEN full-length enriched library, clone:9830108D13 product:SIMILAR TO MYOSIN, HEAVY POLYPEPTIDE 2, SKELETAL MUSCLE, ADULT homolog [Mus musculus], full insert sequence. [AK036437] KLA .97 1.04 1.02 1.02 .95 1.02 .95
ATP 1.00 .98 1.05 1.00 .95 1.08 .97
KLA/ATP .95 1.00 .94 .99 .95 .98 .99
Myh2
KLA  ATP  ATP+KLA
 NM_001039545 myosin, heavy polypeptide 2, skeletal muscle, adult (Myh2), mRNA [NM_001039545] KLA .99 .98 1.03 1.02 .98 .98 1.01
ATP 1.01 .98 .98 1.01 .97 .99 .95
KLA/ATP .95 1.00 1.05 1.00 .96 .99 1.02
Myh3
KLA  ATP  ATP+KLA
 NM_001099635 myosin, heavy polypeptide 3, skeletal muscle, embryonic (Myh3), mRNA [NM_001099635] KLA 1.01 .97 .95 1.07 1.08 1.08 1.07
ATP 1.02 .97 .98 1.02 .94 .96 1.09
KLA/ATP 1.03 1.05 1.03 1.17 1.73 2.01 1.22
Myh4
KLA  ATP  ATP+KLA
 NM_010855 myosin, heavy polypeptide 4, skeletal muscle (Myh4), mRNA [NM_010855] KLA 1.06 1.00 1.00 1.02 1.06 1.06 1.01
ATP .99 1.04 1.02 .98 .96 1.02 1.06
KLA/ATP 1.01 1.00 1.00 1.04 .99 1.00 1.03
Myh6
KLA  ATP  ATP+KLA
 NM_010856 myosin, heavy polypeptide 6, cardiac muscle, alpha (Myh6), mRNA [NM_010856] KLA 1.00 1.01 1.00 .99 1.00 .98 1.02
ATP 1.00 .99 .96 .98 1.01 1.01 .98
KLA/ATP 1.03 1.04 1.01 1.01 .99 1.00 1.02
Myh7
KLA  ATP  ATP+KLA
 NM_080728 myosin, heavy polypeptide 7, cardiac muscle, beta (Myh7), mRNA [NM_080728] KLA 1.06 1.13 1.14 1.07 1.09 1.06 1.03
ATP .96 1.01 1.09 1.05 1.15 1.16 1.12
KLA/ATP 1.01 1.05 1.02 .98 1.29 1.62 1.09
Myh8
KLA  ATP  ATP+KLA
 NM_177369 myosin, heavy polypeptide 8, skeletal muscle, perinatal (Myh8), mRNA [NM_177369] KLA 1.03 .98 1.04 .99 1.02 .99 .97
ATP 1.06 1.07 .97 .99 .98 .98 1.01
KLA/ATP 1.11 1.11 1.05 1.03 .98 1.07 .95
Myh9
KLA  ATP  ATP+KLA
 NM_022410 myosin, heavy polypeptide 9, non-muscle (Myh9), transcript variant 1, mRNA [NM_022410] KLA .69 .65 .55 .57 .70 1.14 .82
ATP .91 .98 1.08 .80 .77 .99 .84
KLA/ATP .62 .66 .69 .49 .47 .54 .70
Prf1
KLA  ATP  ATP+KLA
 NM_011073 perforin 1 (pore forming protein) (Prf1), mRNA [NM_011073] KLA .99 1.02 1.05 1.08 1.00 1.03 .98
ATP 1.00 .97 1.03 .97 .97 .98 .91
KLA/ATP 1.07 .99 .93 .98 .98 .95 .99
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rac2
KLA  ATP  ATP+KLA
 NM_009008 RAS-related C3 botulinum substrate 2 (Rac2), mRNA [NM_009008] KLA 1.55 1.68 1.86 2.15 3.36 3.59 3.74
ATP 1.13 1.16 .74 .99 .84 .91 1.66
KLA/ATP 1.59 1.71 1.19 1.56 1.21 1.60 3.48
Rac3
KLA  ATP  ATP+KLA
 NM_133223 RAS-related C3 botulinum substrate 3 (Rac3), mRNA [NM_133223] KLA 2.03 2.20 2.64 2.18 2.95 2.29 1.41
ATP 1.02 1.12 .94 1.42 1.16 .84 .87
KLA/ATP 2.30 2.32 1.57 2.55 1.75 1.47 1.61
Sgca
KLA  ATP  ATP+KLA
 NM_009161 sarcoglycan, alpha (dystrophin-associated glycoprotein) (Sgca), mRNA [NM_009161] KLA .96 1.06 1.08 1.01 1.06 1.10 1.08
ATP 1.00 .99 1.04 1.04 1.06 .90 1.05
KLA/ATP .98 .96 1.06 1.03 1.18 1.17 1.11
Sgcb
KLA  ATP  ATP+KLA
 AK009080 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310001O14 product:unclassifiable, full insert sequence. [AK009080] KLA 1.32 1.24 1.20 1.23 1.10 1.06 .97
ATP .93 .85 .88 .89 .94 .93 1.01
KLA/ATP 1.19 1.13 .98 .92 1.03 1.04 .97
Sgcb
KLA  ATP  ATP+KLA
 NM_011890 sarcoglycan, beta (dystrophin-associated glycoprotein) (Sgcb), mRNA [NM_011890] KLA 2.98 2.85 3.65 3.67 3.43 2.59 1.47
ATP 1.15 1.07 1.28 1.20 1.19 1.03 1.42
KLA/ATP 2.87 3.08 3.92 3.05 2.71 2.38 1.91
Sgcd
KLA  ATP  ATP+KLA
 NM_011891 sarcoglycan, delta (dystrophin-associated glycoprotein) (Sgcd), mRNA [NM_011891] KLA 1.08 1.07 1.01 1.01 1.07 .96 .93
ATP 1.00 .95 1.03 1.08 1.00 .98 1.01
KLA/ATP .97 .97 1.08 1.03 .95 1.01 1.03
Sgcg
KLA  ATP  ATP+KLA
 NM_011892 sarcoglycan, gamma (dystrophin-associated glycoprotein) (Sgcg), mRNA [NM_011892] KLA .94 .94 1.05 1.06 1.00 1.02 .98
ATP 1.02 .98 1.19 1.08 1.10 1.14 .90
KLA/ATP 1.02 1.06 1.09 1.22 1.13 1.08 .82